Global Genomics Group (G3) and Quintiles have entered a collaboration to investigate novel biomarkers and biological pathways for use in the development of diagnostic tools and treatments for cardiovascular diseases. Expression Analysis (EA), a Quintiles company, will conduct RNA sequencing, microRNA sequencing and methylation analysis in the GLOBAL (Genetic LOci and Burden of Atherosclerotic Lesions) clinical study.   The study aims to identify disease-related pathways, new drug targets, and bi...